Assessment of user safety, exposure and risk to veterinary medicinal products in the European Union

Regulatory Toxicology and Pharmacology

Volumn 50, Issue 1, 2008, Pages 114-128

  Woodward, K N ^a  

^a Schering Plough Animal Health   (United Kingdom)

Author keywords

Exposure assessment; Pharmacovigilance; Risk assessment; Risk communication; User safety; Veterinary drugs

Indexed keywords

ARTICLE; DRUG SURVEILLANCE PROGRAM; ENVIRONMENTAL FACTOR; EUROPE; MEDICAL ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; VETERINARY MEDICINE;

ANIMALS; EUROPEAN UNION; LEGISLATION, DRUG; LEGISLATION, VETERINARY; RISK ASSESSMENT; VETERINARY DRUGS;

EID: 37349111599     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2007.10.007     Document Type: Article

References (181)

1. ACGIH, 1950. Threshold limit values for 1950. A. M. A. Arch. Ind. Hyg. Occup. Med. 2, 98-100.
2. Ames R.G., Brown S.K., Rosenberg J., Jackson R.J., Stratton J.W., and Quenon S.G. Health symptoms and occupational exposure to flea control products among California pet handlers. Am. Ind. Hyg. Assoc. J. 50 (1989) 466-472
3. Anon. Immobilon: why the VPC suspended the licence. Vet. Rec. 99 (1976) 156
4. Anon, 2001. Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products. Official Journal of the European Union, L 311, 1-66 as amended by Directive 2004/28/EC of the European Parliament and the Council of 31 march 2004 amending Directive 2001/82/EC on the Community code relating to veterinary medicinal products. Official J. Eur. Union, L 136, 58-84.
5. Anon. Cutaneous drug reaction reports. Am. J. Clin. Dermatol. 3 (2002) 223-227
6. Anwar W.A., Salama S.I., el Serafy M.M., Hemida S.A., and Hafez A.S. Chromosomal aberrations and micronucleus frequency in nurses occupationally exposed to cytotoxic drugs. Mutagenesis 9 (1994) 35-317
7. Australian Pesticides & Veterinary Medicines Authority, 2006. The reconsideration of selected sheep ectoparasiticide products and their associated labels. Prelimiary Review Findings, vol. 1 of 2. Available from: .
8. Bedello P.G., Goitre M., Cane D., and Roncarolo G. Allergic contact dermatitis to Bayo-N-OX-1. Contact Derm. 12 (1985) 284
9. Belhadjali H., Maguerry M.C., Journe F., Giordano-Labadie F., Lefevre H., and Bazex J. Allergic and photoallergic contact dermatitis in a pig breeder with prolonged photosensitivity. Photodermatol. Photoimmunol. Photomed. 18 (2002) 52-53
10. bin Zakaria M., Lerche N.W., Chomel B.B., and Kass P.H. Accidental injuries associated with nonhuman primate exposure at two regional primate research centers (USA): 1988-1993. Lab. Anim. Sci. 44 (1996) 298-304
11. Bird G.L., and Williams R. Anaesthesia-related liver disease. Monogr. Allergy 30 (1992) 174-191
12. Bliski B. Needlestick injuries in nurses-the Poznań study. Int. J. Occup. Med. Environ. Health 18 (2005) 251-254
13. BMA, 1987. The measurement of risk. In: Living With Risk. John Wiley & Sons, Chichester, pp. 19-28.
14. Breckenridge A. For the good of the patient: risks and benefits of medicines. Pharmacoepidemiol. Drug Saf. 12 (2003) 145-150
15. Brown, R.H., 1988. Sampling and analysis of industrial air. In: IARC Scientific Publications, 85, 149-163.
16. Brown R.C. Protection against dust by respirators. Int. J. Occup. Saf. Ergonom. 1 (1995) 14-28
17. Burgaz S., Karahalil B., Terzioglu F., Ancel G., Anzion R.B., Bos R.P., and Huttner E. Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by analysis of chromosomal aberrations. Hum. Exp. Toxicol. 21 (2002) 129-135
18. Burke F.D., and Brady O. Veterinary and industrial high pressure injection injuries. Br. Med. J. 312 (1996) 1436
19. Burkhart J., and Stobbe T.J. Real-time measurement and control of waste gases during veterinary surgeries. Am. J. Ind. Hyg. Assoc. J. 51 (1990) 640-645
20. Byhahn C., Wilke H.J., and Westphal K. Occupational exposure to volatile anaesthetics: epidemiology approaches to reducing the problem. CNS Drugs 15 (2001) 197-215
21. Cattani M., Cena K., Edwards J., and Pisaniello D. Potential dermal and inhalation exposure to chlorpyrifos in Australian pesticide workers. Ann. Occup. Hyg. 45 (2001) 299-308
22. Cerniglia C.E., and Kotarski S. Evaluation of veterinary drug residues in food for their potential to affect human intestinal flora. Regulat. Toxicol. Pharmacol. 29 (1999) 238-261
23. Cerniglia C.E., and Kotasrski S. Approaches in the safety evaluations of antimicrobial agents in food to determine the effects on the human intestinal microflora. J. Vet. Pharmacol. Ther. 28 (2005) 3-20
24. Cherie J.W., and Hughson G.W. The validity of the EASE Expert System for inhalation exposures. Ann. Occup. Hyg. 49 (2005) 125-134
25. Choi J.-I., and Kim C.S. Mathematical analysis of particle deposition in human lungs: an improved single path transport model. Inhal. Toxicol. 19 (2007) 925-939
26. Chiu W.A., Barton H.A., DeWoskin R.S., Schlosser P., Thompson C.M., Sonawane B., Lipscomb J.C., and Krishnan K. Evaluation of physiologically based pharmacokinetic models for use in risk assessment. J. Appl. Toxicol. 27 (2007) 218-237
27. Cohen B.S., Harley N.H., and Lippmann M. Bias in air sampling techniques used to measure inhalation exposure. Am. Ind. Hyg. Assoc. J. 45 (1984) 187-192
28. Combes R.S., and Warren D.A. Characterizing and controlling industrial dust: a case study in small particle measurement. Environ. Monit. Assess. 106 (2005) 43-58
29. Couzens G., and Burke F.D. Veterinary high pressure injection injuries with inoculations in larger animals. J. Hand Surg. 20 (1995) 497-499
30. Creely K.S., Tickner J., Soutar A.J., Hughson G.W., Pryde D.E., Warren N.D., Rae R., Money C., Phillips A., and Cherie J.W. Evaluation and further development of EASE Model 2.0. Ann. Occup. Hyg. 49 (2005) 135-145
31. Crown L.A., and Smith R.B. Accidental veterinary antibiotic injection into a farm worker. Tenn. Med. 92 (1999) 339-340
32. Crump K.S. Statistical issues with respect to workplace protection factors for respirators. J. Occup. Environ. Hyg. 4 (2007) 208-214
33. Davenport H.T., Halsey M.J., Wardley-Smith B., and Bateman P.E. Occupational exposure to anaesthetics in 20 hospitals. Anaesthesia 35 (1980) 354-359
34. Davis R.J., and Pepys J. Asthma due to inhaled chemical agents-the macrolide antibiotic spiramycin. Clin. Allergy 1 (1975) 99-107
35. Dayan A.D. Allergy to antimicrobial residues in food: an assessment of the risk to man. Vet. Microbiol. 35 (1993) 213-226
36. Dourson M., Charnley G., and Scheuplein R. Differential sensitivity of children and adults to chemical toxicity. II. Risk and regulation. Regulat. Toxicol. Pharmacol. 35 (2002) 448-467
37. Dreesen D.W., Jones G.L., Brown J., and Rawlings C.A. Monitoring for trace anesthetic gases in a veterinary teaching hospital. J. Am. Vet. Med. Assoc. 179 (1981) 797-799
38. Droz P.O., Wu M.M., Cumberland W.G., and Berode M. Variability in biological monitoring of solvent exposure. I. Development of a population physiological model. Br. J. Ind. Med. 46 (1989) 447-460
39. Duggan A., Charnley G., Chen W., Chukwudebe A., Hawk R., Krieger R.I., Ross J., and Yarborough C. Di-alkyl phosphate biomonitoring data: assessing cumulative exposure to organophosphate pesticides. Regulat. Toxicol. Pharmacol. 37 (2003) 382-395
40. ECETOC, 1993. Percutaneous Absorption. Monograph No. 20, ECETOC, Brussels, Belgium.
41. European Commission, 2004. Guidance Document on Dermal Absorption. Sanco/222/2000 rev. 7. (Available from European Commission website ).
42. European Commission Joint Research Centre, 2003. Technical Guidance Document on Risk Assessment in Support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances, Commission Regulation (EC) No. 1488/94 on Risk Assessment for Existing Substances, Directive 98/8/EC of the European Parliament and of the Council Concerning Placing of Biocidal Products on the Market. Part I. EUR 20418 EN/1, pp. 35-77.
43. European Medicines Agency, 2003. Guideline on user safety for pharmaceutical veterinary medicinal products. EMEA/CVMP/543/03-FINAL. (Available from EMEA website ).
44. European Medicines Agency, 2006. Guideline on user safety for immunological veterinary products. EMEA/CVMP/54533/2006-CONSULTATION. (Available from EMEA website ).
45. Fairhurst S. The uncertainty factor in the setting of occupational exposure standards. Ann. Occup. Hyg. 39 (1995) 375-385
46. Fairhurst S. Industrial toxicology and hygiene. In: Ballantyne B., Marrs T.C., and Syversen T. (Eds). General and Applied Toxicology. second ed. (2000), Macmillan, London 1473-1488
47. Firn S. Accidental poisoning by an animal-immobilising agent. Lancet ii (1973) 95-96
48. Fiserova-Bergerova V. Development of biological exposure indices (BEIs) and their implementation. Appl. Ind. Hyg. 2 (1987) 87-92
49. Fiserova-Bergerova V. Application of toxicokinetic models to establish biological exposure indicators. Ann. Occup. Hyg. 34 (1990) 639-651
50. Francalanci M., Gola M., Giorgini S., Muccinelli A., and Sertoli A. Occupational photocontact dermatitis from olaquindox. Contact Derm. 15 (1986) 112-114
51. Fucic A., Jazbec A., Mijic A., Seso-Simic D., and Tomek R. Cytogenetic consequences after occupational exposure to antineoplastic agents. Mutat. Res. 416 (1998) 59-66
52. Galer D.M., and Monro A.M. Veterinary drugs no longer need testing for carcinogenicity in rodent bioassays. Regulat. Toxicol. Pharmacol. 28 (1998) 115-123
53. Gardner R.J., Hampton J., and Causton J.S. Inhalation anaesthetics-exposure and control during veterinary surgery. Ann. Occup. Hyg. 35 (1991) 377-388
54. Georgopoulos P.G., and Lioy P.J. Conceptual and theoretical aspects of human exposure and dose assessment. J. Expo. Anal. Environ. Epidemiol. 4 (1994) 253-285
55. Goodrich P.G.E. Accidental self-injection. Vet. Rec. 100 (1977) 458-459
56. Green C.J. Anaesthetic gases and health risks to laboratory personnel. Lab. Anim. 15 (1981) 397-403
57. Gwynne Jones D.P. Accidental self-injection with oil-based veterinary vaccines. N.Z. Med. J. 109 (1996) 363-365
58. Harper M., and Guild L.V. Experience in the use of the NIOSH diffusive sampler evaluation protocol. Am. Ind. Hyg. Assoc. J. 57 (1996) 1115-1123
59. Harper M., Muller B.S., and Bartolucci A. Determining particle size distributions in the inhalable size range for wood dust collected by air samplers. J. Environ. Monit. 4 (2002) 642-647
60. Harper M., and Muller B.S. An evaluation of total and inhalable samplers for the collection of wood dust in three wood products industries. J. Environ. Monit. 4 (2002) 648-656
61. Hays S.M., Becker R.A., Leung H.W., Aylward L.L., and Pyatt D.W. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health perspective. Regulat. Toxicol. Pharmacol. 47 (2007) 96-109
62. Hearl F.J. Industrial hygiene sampling and applications to ambient silica monitoring. J. Expo. Anal. Environ. Epidemiol. 7 (1997) 279-289
63. Henderson R.F., Bechtold W.E., Bond J.A., and Sun J.D. The use of biological markers in toxicology. Crit. Rev. Toxicol. 20 (1989) 65-82
64. Henderson K.A., and Matthews I.P. Staff exposure to anaesthetic gases in theatre and non theatre areas. Eur. J. Anaesthesiol. 17 (2000) 149-151
65. Herrman J., and Younes M. Background to the ADI/TDI/PTWI. Regulat. Toxicol. Pharmacol. 30 (1999) S109-S113
66. Hext P.M. Inhalation toxicology. In: Ballantyne B., Marrs T.C., and Syversen T. (Eds). General and Applied Toxicology (2000), Macmillan, London 587-601
67. Hill D.J., Langley R.L., and Morrow W.M. Occupational injuries and illnesses reported by zoo veterinarians in the United States. J. Zoo Wildl. Med. 29 (1998) 371-385
68. Hjorth N., and Weismann K. Occupational dermatitis among veterinary surgeons caused by spiramycin, tylosin and penethamate. Acta Derm. Venereol. 53 (1973) 229-232
69. Hoerauf K., Lierz M., Schrögendorfer K., Felleitrt P., Madei W., Lierz P., and Brunnberg L. Occupational exposure to waste anesthetic gases during veterinary surgery. Zentralbl Hyg. Umweldmed. 201 (1998) 405-412
70. Holden W.L. Benefit-risk analysis, A brief review and proposed quantitative approaches. Drug Saf. 26 (2003) 853-862
71. Howie R.M. Respiratory protective equipment. Occup. Environ. Med. 62 (2005) 423-428
72. Illing H.P.A. Extrapolation from toxicity data to occupational exposure limits: some considerations. Ann. Occup. Hyg. 35 (1991) 569-580
73. Illing H.P.A. Possible considerations for toxic risk assessment. Hum. Exp. Toxicol. 10 (1991) 215-219
74. Illing H.P.A. Are societal judgments being incorporated into uncertainty factors used in toxicological risk assessment?. Regulat. Toxicol. Pharmacol. 29 (1999) 300-308
75. Illing H.P.A. The importance of risk perception and risk communication for toxicological risk assessment. Toxicity and Risk Context Principles and Practice (2001), Taylor and Francis, London 43-56
76. International Programme on Chemical Safety, 1994. Assessing Human Health Risks of Chemicals: Derivation of Guidance Values for Health-Based Exposure Limits. Environmental Health Criteria 170, IPCS, WHO, Geneva.
77. International Programme on Chemical Safety, 2001. Biomarkers in risk assessment: validity and validation. Environmental Health Criteria 222, IPCS, WHO, Geneva.
78. International Programme on Chemical Safety, 2006. Dermal Absorption. Environmental Health Criteria 235, IPCS, WHO, Geneva.
79. JECFA, 1957. Procedures for the Testing of Intentional Food Additives to Establish their Safety for Use. Second Report of the Joint FAO/WHO Expert Committee on Food Additives, WHO Technical Report Series 144, WHO, Geneva.
80. JECFA, 1987. Principles for the Safety Assessment of Food Additives and Contaminants in Food. Environmental Health Criteria 70. International Program on Chemical Safety, WHO, Geneva.
81. Jaques P.A., and Kim C.S. Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women. Inhal. Toxicol. 12 (2000) 715-731
82. Jones D.P. Accidental self inoculation with oil based veterinary vaccines. N.Z. Med. J. 109 (1996) 363-365
83. Keck G., and Ibrahim C. Veterinary pharmacovigilance: between regulation and science. J. Vet. Pharmacol. Ther. 24 (2001) 22-27
84. Keller W.C., Battaller N., and Oeller D.S. Processing and evaluation of adverse drug reaction reports at the Food and Drug Administration Center for Veterinary Medicine. J. Am. Vet. Med. Assoc. 213 (1998) 208-211
85. Kirman C.R., Sweeney L.M., Mek M.E., and Gargas M.L. Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling. Regulat. Toxicol. Pharmacol. 38 (2003) 345-367
86. Korczynski R.E. Anaesthetic gas exposure in veterinary clinics. Appl. Occup. Environ. Hyg. 14 (1999) 384-390
87. ® 300. J. Toxicol.: Clin. Toxicol. 34 (1996) 574
88. Kuroda Y., Nacionales D.C., Akaogi J., Reeves W.H., and Satoh M. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccines. Biomed. Pharmacother. 58 (2004) 325-337
89. Lacey S.E., Conroy L.M., Franke J.E., Wadden R.A., Hedeker D.R., and Forst L.S. Personal dust exposures at a food processing facility. J. Agromed. 11 (2006) 49-58
90. Leira H.L., and Baalsrud K.J. Operator safety during injection vaccination of fish. Dev. Biol. Stand. 90 (1997) 383-387
91. Leung H.-W., and Paustenbach D.J. Application of pharmacokinetics to derive biological exposure indexes from threshold limit values. Am. Ind. Hyg. Assoc. J. 49 (1988) 445-450
92. Leung H.-O. Use of physiologically based pharmacokinetic models to establish biological exposure indices. Am. Ind. Hyg. Assoc. J. 53 (1992) 369-374
93. Löndahl J., Massling A., Pagels J., Swietlicki E., Vaclavik E., and Loft S. Size-resolved respiratory tract deposition of fine and ultrafine hydrophobic and hygroscopic aerosol particles during rest and exercise. Inhal. Toxicol. 19 (2007) 109-116
94. Luo W., Medrek S., Misra J., and Nohynek G.J. Predicting human skin absorption of chemicals: development of a novel quantitative structure activity relationship. Toxicol. Ind. Health 23 (2007) 39-45
95. Machera K., Goumeno M., Kapetanakis E., Kalamarakis A., and Glassa R. Determination of potential dermal and inhalation exposure of operators, following application of the fungicide penconazole in vineyards and greenhouses. Fresenius Environ. Bull. 10 (2001) 464-469
96. Machera K., Goumeno M., Kapetanakis E., Kalamarakis A., and Glassa R. Determination of potential dermal and inhalation operator to malathion in greenhouses with whole body dosimetry method. Ann. Occup. Hyg. 47 (2003) 61-70
97. Marquart J., Brouwer D.H., Gijsbers J.H.J., Links I.H.M., Warren N., and Van Hemmen J.J. Determinants of dermal exposure relevant for exposure modeling in regulatory risk assessment. Ann. Occup. Hyg. 47 (2003) 599-607
98. McHattie G.V., Rackham M., and Teasdale E.L. The derivation of occupational exposure limits in the pharmaceutical industry. J. Soc. Occup. Med. 38 (1988) 105-108
99. Menezes de Pádua C.A., Uter W., and Schnuch A. Contact allergy to topical drugs: prevalence in a clinical setting and estimation of frequency at the population level. Pharmacoepidemiol. Drug Saf. 16 (2007) 377-384
100. Meyboom R.H.B., and Egberts A.C.G. Comparing therapeutic benefit and risk. Thérapie 54 (1999) 29-34
101. Meyer R.E. Anesthesia hazards to animal workers. Occup. Med. 14 (1999) 225-233
102. Milligan J.E., Sablan J.L., and Short C.E. A survey of waste anesthetic gas concentrations in the U.S. Air Force veterinary surgeries. J. Am. Vet. Med. Assoc. 177 (1980) 1021-1022
103. Miller L.L. Risk/benefit assessment: the "greased pig" of drug development. Drug Inf. J. 27 (1993) 1011-1020
104. Moore R.M., Davis Y.M., and Kaczmarek R.G. An overview of occupational hazards among veterinarians with particular reference to pregnant women. Am. Ind. Hyg. Assoc. J. 54 (1993) 113-120
105. Naumann B.D., Sargent E.V., Sharkman B.S., Fraser W.J., Becker G.T., and Kirk G.D. Performance-based occupational exposure limits for pharmaceutical active ingredients. Am. Ind. Hyg. Assoc. J. 57 (1996) 33-42
106. Neal N.C., and Burke F.D. High pressure injection injuries. Injury 22 (1991) 467-470
107. Neuberger J., and Williams R. Halothane hepatitis. Dig. Dis. 61 (1988) 52-64
108. Nicas M., and Neuhaus J. Variability in respiratory protection and the assigned protection factor. J. Occup. Environ. Hyg. 1 (2004) 99-109
109. Nielsen G.D., Wolkoff P., and Alarie Y. Sensory irritation: risk assessment approaches. Regulat. Toxicol. Pharmacol. 48 (2007) 6-18
110. NIOSH, 2004. Preventing Occupational Exposure to Antineoplastic and other hazardous drugs in healthcare settings. NIOSH Publication No. 2004-165. Available from: .
111. Northage C. EASEing into the future. Ann. Occup. Hyg. 49 (2005) 99-101
112. Notø H., Halgard K., Daae H.L., Bentsen R.K., and Eduard W. Comparative study of an inhalable and a total dust sampler for personal sampling of dust and polycyclic aromatic hydrocarbons in the gas and particulate phase. Analyst 121 (1996) 1191-1196
113. Olajos E.J., and Salem H. Occupational toxicology. In: Ballantyne B., Marrs T.C., and Syversen T. (Eds). General and Applied Toxicology. second ed. (2000), Macmillan, London 1453-1471
114. O'Neill J.K., Richards S.W., Ricketts D.M., and Patterson M.H. The effects of injection of bovine vaccine into a human digit: a case report. Environ. Health 4 (2005) 21
115. Oppl R., Kalberlah F., Evans P.G., and Van Hemmen J.J. A toolkit for dermal risk assessment and management: an overview. Ann. Occup. Hyg. 47 (2003) 629-640
116. O'Sullivan S.T., O'Donoghue J.M., and O'Connor T.P.F. Occupational high-pressure injection injury to the hand. Dermatology 194 (1997) 311
117. Paggiaro P.L., Loi A.M., and Toma G. Bronchial asthma and dermatitis in a chick breeder. Clin. Allergy 9 (1979) 571-574
118. Patterson C.J., LaVenture M., Hurley S.S., and Davis J.P. Accidental self-inoculation with Mycobacterium paratuberculosis bacterin (Johne's bacterin) by veterinarians in Wisconsin. J. Am. Vet. Med. Assoc. 192 (1988) 1197-1199
119. Paull J.M. The origin and basis of threshold limit values. Am. J. Ind. Med. 5 (1984) 227-238
120. Peretz C., de Pater N., de Monchy J., Oostenbrink J., and Heederik D. Assessment of exposure to wheat flour and the shape of its relationship with specific sensitization. Scand. J. Work Environ. Health 31 (2005) 65-74
121. Pétavy-Catala C., Machet L., and Vaillant L. Consort contact urticaria due to amoxicillin. Contact Derm. 44 (2001) 246
122. Poole A.G., Shane S.M., Kearney M.T., and Rehn W. Survey of occupational hazards in companion animal practices. J. Am. Vet. Med. Assoc. 212 (1998) 1386-1388
123. Potts D.L., and Craft B.F. Occupational exposure of veterinarians to waste anesthetic gases. Appl. Ind. Hyg. 3 (1988) 132-138
124. Potts R.O., and Guy R.H. Predicting skin permeability. Pharm. Res. 9 (1992) 663-669
125. Puskar M.A., Harkins J.M., Moomey J.D., and Hecker L.H. Internal wall losses of pharmaceutical dusts during closed-face, 37-mm polystyrene cassette sampling. Am. Indust. Hyg. Assoc. J. 52 (1991) 280-286
126. Reddy M.B., Guy R.H., and Bunge A.L. Does epidermal turnover reduce percutaneous penetration?. Pharm. Res. 17 (2000) 1414-1419
127. Rhodes C.R. Principles of testing for acute effects. In: Ballantyne B., Marrs T.C., and Syversen T. (Eds). General and Applied Toxicology (2000), Macmillan, London 33-54
128. Richardson G.D., Links I.I., and Windsor P.A. Gudair (OJD) vaccine self-inoculation: a case for early debridement. Med. J. Aust. 183 (2005) 151-152
129. Rigas M.L., Okino M.S., and Quackenboss J.J. Use of a pharmacokinetic model to assess chlorpyrifos exposure and dose in children, based on urinary biomarker measurements. Toxicol. Sci. 61 (2001) 374-381
130. Rodrígues-Morales A., Llamazares A.A., Benito R.P., and Cóchera C.M. Fixed drug eruption from quinolones with a positive lesional patch test to ciprofloxacin. Contact Derm. 44 (2001) 246
131. Rogers M.D. Risk analysis under uncertainty, the precautionary principle, and the new EU chemicals strategy. Regulat. Pharmacol. Toxicol. 37 (2003) 370-381
132. Rudzki E., and Rebandel P. Airborne contact dermatitis due to ethacridine lactate in a veterinary surgeon. Contact Derm. 45 (2001) 234
133. Sanchez-Perez J., Lopez M.P., and Garcia-Diez A. Airborne allergic dermatitis from olaquindox in a rabbit breeder. Contact Derm. 46 (2002) 185
134. Schneider T., Vermeulen R., Brouwer D.H., Cherrie J.W., Kromhout H., and Fogh C.L. Conceptual model for assessment of dermal exposure. Occup. Environ. Med. 56 (1999) 765-773
135. Schneider T., Schlünssen V., Vinzents P.S., and Kildesø J. Passive sampler used for simultaneous measurement of breathing zone size distribution, inhalable dust concentration and other size fractions involving large particles. Ann. Occup. Hyg. 46 (2002) 187-195
136. Schuchman S.M., Frye F.L., and Barrett R.P. Toxicities and hazards for clinicians in small animal practice. Vet. Clin. North Am. 5 (1975) 727-735
137. Shah N.M., Mangat G.K., Balakrishnan C., Buch V.I., and Joshi V.R. Accidental self-injection with Freund's complete adjuvant. J. Assoc. Phys. India 49 (2001) 366-368
138. Sillis M. Disposal of veterinary sharps. Vet. Rec. 152 (2003) 116
139. Sitarek K., Wesolowski W., Kucharska M., and Celichowski G. Concentrations of anaesthetic gases in hospital operating theatres. Int. J. Occup. Med. Environ. Health 13 (2000) 61-66
140. Smith D.R., and Leggat P.A. Needlestick and sharps injuries among nursing students. J. Adv. Nurs. 51 (2005) 449-455
141. Søeborg T., Basse L.H., and Halling-Sørensen B. Risk assessment of topically applied products. Toxicology 236 (2007) 140-148
142. Soutar C.A., Miller B.G., Gregg N., Jones A.D., Cullen R.T., and Bolton R.E. Assessment of human risks from exposure to low toxicity occupational dusts. Ann. Occup. Hyg. 41 (1997) 123-133
143. Spickler A.R., and Roth J.A. Adjuvants in veterinary vaccines: mode of action and adverse effects. J. Vet. Intern. Med. 17 (2003) 273-281
144. Stimpfel T.M., and Gershey E.L. Selecting anaesthetic agents for human safety and animal recovery after surgery. FASEB J. 5 (1991) 2099-2104
145. Tatum V.L., Ray A.E., and Rovell-Rixx D.C. The performance of personal inhalable dust samplers in wood-products industry facilities. Appl. Occup.Environ. Hyg. 16 (2001) 763-769
146. Tennant D.R. Risk analysis. Food Chemical Safety. In: Watson D.H. (Ed). Contaminants vol. 1 (2001), CRC Press/Woodhead Publishing Ltd., Cambridge 15-36
147. Testa A., Giachelia M., Palma S., Appolloni M., Padua L., Tranfo G., Spagnoli M., Tirindelli D., and Cozzi R. Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms. Toxicol. Appl. Pharmacol. 223 (2007) 46-55
148. Thomas R.S., Bigelow P.L., Keefe T.J., and Yang R.S.H. Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation. Am. Ind. Hyg. Assoc. J. 57 (1996) 23-32
149. Thorpe A. Assessment of personal direct-reading dust monitors for the measurement of airborne inhalable dust. Ann. Occup. Hyg. (2007) 97-112
150. Tickner J., Friar J., Creely K.S., Cherrie J.W., Pryde D.E., and Kingston J. The development of the EASE model. Ann. Occup. Hyg. 49 (2005) 103-110
151. Truchon G., Tardif R., Droz P.-O., Charest-Tardif G., and Pierrehumbert G. Biological exposure indicators: quantification of biological variability using toxicokinetic modeling. J. Occup. Environ. Med. 3 (2006) 137-143
152. Ursin C., Hansen C.M., Van Dyk J.W., Jensen P.O., Christensen I.J., and Ebbehoej J. Permeability of commercial solvents through living human skin. Am. Ind. Hyg. Assoc. J. 56 (1995) 651-660
153. US EPA, 1996. Occupational and residential exposure Guidelines. OPPTS 875.1200 Dermal Exposure-Indoor. EPA 712-C-96-209.
154. Van Hemmen J.J. Predictive exposure modeling for pesticide registration purposes. Ann. Occup. Hyg. 37 (1993) 541-564
155. Van Hemmen JJ. EUROPOEM, a predictive occupational exposure database for registration purposes of pesticides. Appl. Occup. Environ. Hyg. 16 (2001) 246-250
156. Van Hemmen J.J., Auffarth J., Evans P.G., Rajan-Sithanparanadarajah B., Marquart H., and Oppl R. RISKOFDERM: risk assessment of occupational dermal exposure to chemicals. An introduction to a series of papers on the development of a toolkit. Ann. Occup. Hyg. 47 (2003) 595-598
157. Van-Wendel-de-Joode B., Brouwer D.H., Vermeulen R., Van Hemmen J.J., Heederik D., and Kromhout H. DREAM: a method for semi-quantitative dermal exposure assessment. Ann. Occup. Hyg. 47 (2003) 71-87
158. Vaudrey J.C. Accidental injection with Immobilon. Vet. Rev. 94 (1974) 52
159. Vaughan N., and Rajan-Sithamparanadarajah B. Meaningful workplace protection factor measurement: experimental protocols and data treatment. Ann. Occup. Hyg. 49 49 (2005) 549-561
160. Veerhuizen M.F., Wright T.J., McManus R.F., and Owens J.G. Analysis of reports of human exposure to Micotil 300 (tilmicosin injection). J. Am. Vet. Med. Assoc. 229 (2006) 1737-1742
161. Villière V. An Australian experience of using work practices to establish an exposure model for shearers. Ann. Occup. Hyg. 45 (2001) S103-S105
162. ® 300). J. Toxicol.: Clin. Toxicol. 41 (2003) 229-233
163. Ward G.S., and Byland R.R. Concentrations of methoxyfluorane and nitrous oxide in veterinary operating rooms. Am. J. Vet. Res. 43 (1982) 360-362
164. Ward G.S., and Byland R.R. Concentrations of halothane in veterinary operating and treatment rooms. J. Am. Vet. Med. Assoc. 180 (1982) 174-177
165. Waterfield C.J., and Timbrell J.A. Biomarkers: an overview. In: Ballantyne B., Marrs T.C., and Syversen T. (Eds). General and Applied Toxicology (2000), Macmillan, London 1841-1854
166. Wilkins J.R., and Bowman M.E. Needlestick injuries among female veterinarians: frequency, syringe contents and side-effects. Occup. Med. 47 (1997) 451-457
167. Wilschut A., ten Berge W.F., Robinson P.J., and McKone T.E. Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere 30 (1995) 1275-1296
168. Windsor P.A., Bush R., Links I., and Eppleston J. Injury caused by self-inoculation with a vaccine of a complete Freund's adjuvant nature (Gudair) used for control of ovine paratuberculosis. Aust. Vet. J. 83 (2005) 216-220
169. Wingfield W.E., Ruby D.L., Buchan R.M., and Gunther B.J. Waste anesthetic gas exposures to veterinarians and animal technicians. J. Am. Vet. Med. Assoc. 178 (1981) 399-402
170. Witschger O., Grinshpun S.A., Fauvel S., and Basso G. Performance of personal inhalable aerosol samplers in very slowly moving air when facing the aerosol source. Ann. Occup. Hyg. 48 (2004) 351-368
171. Woodward K.N. Hypersensitivity in humans and exposure to veterinary drugs. Vet. Hum. Toxicol. 33 (1991) 168-172
172. Woodward K.N. Progress with the establishment of maximum residue limits for veterinary drugs in the European Union. Toxicol. Ecotoxicol. News/Rev. 4 (1997) 46-54
173. Woodward K.N. The use of microbiological end-points in the safety evaluation and elaboration of maximum residue limits for veterinary drugs intended for use in food producing animals. J. Vet. Pharmacol. Ther. 21 (1998) 47-53
174. Woodward K.N. Regulation of veterinary drugs. In: Ballantyne B., Marrs T.C., and Syversen T. (Eds). General and Applied Toxicology. second ed. (2000), Macmillan, London 1633-1652
175. Woodward K.N. The evolution of safety assessments for veterinary medicinal products in the European Union. Vet. Hum. Toxicol. 46 (2004) 199-205
176. Woodward K.N. Assessing the safety of veterinary drug residues. In: Watson D.H. (Ed). Pesticides, Veterinary Drugs and Other Residues in Food (2004), CRC Press/Woodhead Publishing Ltd., Cambridge 157-174
177. Woodward K.N. Veterinary pharmacovigilance. Part 4. Adverse reactions in humans to veterinary medicinal products. J. Vet. Pharmacol. Ther. 28 (2005) 185-201
178. Woodward K.N. Veterinary pharmacovigilance. Part 1. The legal basis in Europe. J. Vet. Pharmacol. Ther. 28 (2005) 131-147
179. Woodward K.N. The European veterinary user safety guidelines for pharmaceuticals. Regulat. Affairs J. 18 (2007) 535-540
180. Zielhuis R.L., and van der Kreek F.W. The use of a safety factor in setting health based permissible levels for occupational exposure. Int. Arch. Occup. Environ. Health 42 (1979) 191-201
181. Zielhuis R.L., Noordan P.C., Maas C.L., Kolk J.J., and Illing H.P.A. Harmonisation of criteria documents for standard setting in occupational health: report of a meeting. Regulat. Toxicol. Pharmacol. 13 (1991) 241-262